HTT is an evident candidate gene to target in HD because its genetic knockout or knockdown using CRISPR/Cas9, siRNA, or antisense oligonucleotides (ASO) rescues neurotoxicity8–12. The gene discussed is HTT; the disease is Huntington disease.